
- Telehealth Visits
- Insurance plan information

Michael Kattah, MD
Inflammatory Bowel Disease Gastroenterology • Gastroenterology- Telehealth Visits
- Insurance plan information



Michael Kattah, MD
Inflammatory Bowel Disease Gastroenterology • Gastroenterology- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Michael Kattah is a gastroenterologist who cares for patients with inflammatory bowel disease (IBD) and other disorders involving the digestive tract. He performs upper endoscopies and colonoscopies. He is particularly interested in caring for young adults with IBD and works with pediatric gastroenterologists to help these patients transition from pediatric to adult care.
Kattah's research focuses on ways to better treat patients with IBD. He studies both Crohn's disease and ulcerative colitis (types of IBD) to investigate why people develop IBD and learn how to choose the best medications for individual patients. His lab uses new technologies to understand how specific genes and cell types drive IBD, with the goal of identifying less toxic, more tailored treatments.
Kattah earned his medical degree and doctorate in immunology at Stanford University School of Medicine. He completed a residency in internal medicine at Brigham and Women's Hospital, followed by a fellowship in gastroenterology at UCSF.
In his free time, Kattah enjoys surfing.
Education & training
Board certification
- Gastroenterology, American Board of Internal Med/Gastroenterology
Fellowship
- Gastroenterology, UCSF Graduate Medical Education
Residency
- Internal Medicine, Brigham and Womens Hospital GME
Internship
- Internal Medicine, Brigham and Womens Hospital GME
Degree
- MD, Stanford University School of Medicine
My expertise
My research
Publications
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.